Skip to Content

Hear from women who have been there

SUI patient stories

Take a look into the lives of women who suffered from stress urinary incontinence (SUI) and how they took back control with Altis® Single Incision Sling, a lasting solution for SUI.

“Since the surgery, I have freedom… I don’t have to worry about being near a restroom all the time… I waited 10 years, do not do that. Help is there.”

– Ginny, Licensed nurse practitioner

“If I were to give a word of advice to women who suffered and are suffering in silence like I did, it would be, don’t wait…”

– Tammi, Elementary school teacher
 

“Stress urinary incontinence (SUI) affects a lot more women than we probably know, and the treatment is life-changing in such a positive way that you will never doubt getting it taken care of.”

– Julie, Mother of three

“After I healed from the surgery, I really started feeling like myself again. I was able to do all the things that I wasn’t able to do as easily prior to the surgery. There was no leaking whatsoever.”

– Dana, Mother of three

“I am interested in sharing this journey… this is something that can get fixed and I don’t have to live with it for 20 years… stress incontinence is not okay…”

– Jordan, Special education teacher and mother of four

POP patient stories

Take a look into the lives of women who suffered from pelvic organ prolapse (POP) and how they took back control with lasting solutions for POP.

Lauries story thumbnail

“I have no regrets. I highly recommend the surgery.”

– Laurie, POP patient
Read Laurie’s story

“I really feel like I’m getting my life back.”

– Stacy, living with POP

Subscribe to emails

Subscribe to receive more information on the stress urinary incontinence and pelvic organ prolapse conditions and the solutions available to you.

"*" indicates required fields


By submitting the information on this form, you agree to be contacted and accept Coloplast’s Terms and Conditions and our Privacy Policy.
Confirmation of Consent*
Please check the box to acknowledge that you have read and understood the Confirmation of Consent.
This field is for validation purposes and should be left unchanged.

Looking for more information?

Understanding stress urinary incontinence

Understanding pelvic organ prolapse

Finding the right doctor

Important safety information

Altis® Single Incision Sling System
Important Safety Information

Stress urinary incontinence is a condition in which urine involuntarily leaks at times of increased pressure on the bladder (e.g., coughing, sneezing, laughing, lifting heavy objects, exercise). Stress urinary incontinence can be treated with a surgical procedure in which a mesh sling is implanted to act as a “hammock” to support the urethra, the tube that connects to the bladder that carries urine outside the body. An incontinence sling surgery involves anesthesia and may require an overnight hospital stay.

The Altis Single Incision Sling System is indicated for the treatment of female stress urinary incontinence (SUI) resulting from the urethra not closing properly (urethral hypermobility) and/or weakness of the urethral sphincter (intrinsic sphincter deficiency (ISD)).

Your physician should advise that the Altis Single Incision Sling System is not for females who have the following: are pregnant or have desire for future pregnancy • potential for further growth (e.g., adolescents) • known active urinary tract infection and/or infection in operative field • taking blood thinning medication (anti-coagulant therapy) • abnormal urethra (e.g., fistula, diverticulum) • any condition, including known or suspected pelvic pathology, which could compromise implant or implant placement, and • sensitivity/allergy to polypropylene or polyurethane.

Discuss with your physician:

  • The reason for choosing a mesh sling including the warnings, precautions and risks associated with its use
  • Alternative incontinence treatments that may be appropriate
  • The Altis sling to be implanted is permanent
  • Serious mesh associated complications may result in one or more revision surgeries
  • Partial or complete removal of the mesh may not always be possible or advisable as it may not fully correct these complications
  • New onset (de novo) complications and recurring or worsening SUI can occur
  • There may be unresolved pain with or without mesh explant and varying degrees of scarring may occur
  • Certain underlying conditions may be more susceptible to postoperative bleeding, impaired blood supply, compromised/delayed healing, mesh sling exposure or other complications

Potential additional risks versus benefits of using Altis should be considered in patients with one or more of the following: age-related underlying conditions • autoimmune disease • coagulation disorder • connective tissue disorder • debilitated or immunocompromised state • diabetes • pelvic radiation therapy or chemotherapy • physical characteristics (e.g., body mass index) • renal insufficiency • smoking-related underlying conditions, or • urinary tract anomalies.

Any future pregnancy could negate the benefits of this surgical procedure. Patients should report bleeding, pain, abnormal vaginal discharge or signs of infection at any time.

Complications are known to occur and may be immediate or delayed, localized or systemic, new onset (de novo) or worsening, acute or chronic, transient or permanent, new onset (de novo) or continuing, worsening, transient, or permanent.

Potential complications may include but are not limited to:

  • Abnormal vaginal discharge
  • Abscess
  • Adhesion
  • Allergic reaction, hypersensitivity, or abnormal (maladaptive) immune response
  • Bladder symptoms (e.g., increased daytime frequency, urgency, nocturia (urinating more than once per night), overactive bladder, urinary incontinence)
  • Bleeding/hemorrhage or hematoma
  • Delayed/impaired/abnormal wound healing
  • Dyspareunia (painful intercourse)
  • Exposure, extrusion or erosion of mesh sling or suture into the vagina or other structures and organs
  • Fistula formation (abnormal connection or passageway that forms between two structures in the body)
  • Granuloma (small area of inflammation)/scar tissue formation
  • Hispareunia (male partner pain with intercourse)
  • Infection
  • Inflammation/irritation
  • Necrosis (tissue death)
  • Neuromuscular disorder
  • Pain
  • Palpable mesh (able to be felt by patient and/or partner)
  • Pelvic/urogenital pain
  • Perforation or injury to adjacent muscles, nerves, vessels, structures, or organs (e.g., bone, bladder, urethra, ureters, bowel, vagina)
  • Scarring
  • Seroma (fluid buildup at site of surgery)
  • Sexual dysfunction
  • Sling migration (movement)
  • Suture exposure
  • Ureteral obstruction
  • Urinary tract infection
  • Vaginal tightening/shortening
  • Voiding symptoms (e.g., dysuria (painful urination), urinary retention, incomplete emptying, bladder outlet obstruction, straining, position-dependent voiding, slow stream)
  • Wound dehiscence (re-opening of surgical incision)

This treatment is prescribed by your physician. Discuss the treatment options with your physician to understand the risks and benefits of the various options to determine if a mesh sling is right for you.

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

Minneapolis, MN
PM-03328 02/2024

Important safety information

Restorelle® M, L, XL, Y and Y Contour Polypropylene Mesh
Important Safety Information

Restorelle is a polypropylene mesh device intended to treat uterine or vaginal vault pelvic organ prolapse in women. Restorelle is surgically implanted through a small incision in the abdomen to act as a support to weak or damaged muscles of the uterus or vaginal vault (top of the vagina). Once implanted, the mesh is permanent and not intended to be removed.

Restorelle M, L, XL, Y and Y Contour is indicated for use as a bridging material for sacrocolposuspension/sacrocolpopexy (transabdominal placement via laparotomy, laparoscopic, or robotic approach) where surgical treatment for vaginal vault prolapse is warranted.

Restorelle M, L, XL, Y and Y Contour is not for females who have the following conditions:

  • Pregnancy or desire for future pregnancy
  • Potential for further growth (e.g., adolescents)
  • Pre-existing local or systemic infection. Treat the infection with the appropriate antiseptics and/or antibiotics to eliminate the infection before placing the Restorelle M, L, XL, Y and Y Contour mesh
  • Taking blood thinning medications (anticoagulant therapy)
  • Any condition, including known or suspected pelvic pathology, which could compromise implant or implant placement
  • Sensitivity/allergy to polypropylene

Check with your Physician on the warnings, precautions and risks associated with the use of this mesh. The effectiveness of Restorelle Y Contour has not been validated by a prospective, randomized clinical trial. A thorough assessment of each patient should be made to determine the suitability of a synthetic mesh procedure.

Check with your physician on:

  • alternative prolapse treatments that may be appropriate
  • the reason for choosing a surgical mesh procedure
  • the postoperative risks and potential complications of transabdominal mesh surgery
  • the mesh to be implanted is a permanent implant
  • some complications associated with the implanted mesh may require additional surgery; repeat surgery may not resolve these complications
  • serious adverse tissue responses or infection may require removal of the mesh and complete removal of the mesh may not always be possible
  • individuals who have varying degrees of collagen laydown that may result in scarring

As with all surgical procedures, patients with certain underlying conditions may be more susceptible to postoperative bleeding, impaired blood supply, compromised/delayed healing, or other complications and adverse events.

The risks and benefits of using Restorelle M, L, XL, Y and Y Contour should be considered in patients with: • Age-related underlying conditions • Autoimmune disease • Coagulation disorder • Connective tissue disorder • Debilitated or immunocompromised state • Diabetes • Pelvic radiation therapy or chemotherapy • Physical characteristics (e.g., body mass index) • Smoking-related underlying conditions • Urinary tract anomalies.

Any future pregnancy could negate the benefits of this surgical procedure. Patients should report any bleeding, pain, abnormal vaginal discharge or sign of infection that occur at any time.

Adverse events are known to occur with transabdominal synthetic mesh procedures and implants. Adverse events following mesh implantation may be new onset (de novo), persistent, worsening, transient, or permanent.

Adverse events may include but are not limited to: • Abscess (acute or delayed) • Adhesion/scar formation • Allergy, hypersensitivity or other immune reaction • Bleeding, hemorrhage or hematoma • Bowel Related (Bowel obstruction, Constipation and/or defecatory dysfunction, Fecal incontinence and/or anal sphincter incompetence, temporary inability to pass food and waste through the intestine (ileus)) • Reopening of surgical incision (dehiscence) • Delayed wound healing • Extrusion, erosion or exposure of mesh into the vagina or other structures or organs • Formation of abnormal connection or passageway that forms between two structures in the body (fistula) • Infection • Inflammation (acute or chronic) • Local irritation • Mesh migration • Tissue death (necrosis) • Pain Related (new onset (de novo) and/or worsening painful intercourse (dyspareunia), Neuromuscular symptoms (acute or chronic), Pain (acute or chronic), Partner pain and/or discomfort during intercourse) • Perforation or injury of soft tissue (e.g., ligaments, muscles, nerves, vessels), structures, or organs (e.g., bowel, rectum, bladder, urethra, ureters, vagina) • Fluid buildup at site of surgery (seroma) • Suture erosion • Urinary Related (Bladder storage dysfunction (e.g., increased daytime frequency, urgency, nocturia, overactive bladder, urinary incontinence), Ureteral obstruction, Urinary tract infection, Voiding symptoms (e.g., painful urination (dysuria), urinary retention, incomplete emptying, straining, positional voiding, weak stream) • Vaginal Related (new onset (de novo) or worsening prolapse in untreated compartment, abnormal wound healing (granulation tissue formation), Palpable mesh (able to be felt by patient and/or partner), Recurrent prolapse, Sexual dysfunction, Vaginal discharge (abnormal), Vaginal scarring, tightening, rigidity, shortening and/or contracture.

The occurrence of adverse events may require one or more revision surgeries, including removal of the mesh. Complete removal of the mesh may not always be possible, and additional surgeries may not always fully correct the complications. There may be unresolved pain with or without mesh explantation.

This treatment is prescribed by your physician. Discuss the treatment options with your physician to understand the risks and benefits of the various options to determine if a transabdominal mesh procedure is right for you.

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

PM-07280 / Feb 2024

Axis™ Tutoplast®
Important Safety Information

Axis™ Tutoplast® Processed Dermis is processed from donated human tissue. The US FDA regulates Axis Tutoplast Processed Dermis as a human cell and tissue product and restricts it to homologous use.

Homologous use means Axis Tutoplast Processed Dermis can be used by a qualified healthcare professional to repair, replace, reconstruct or supplement soft tissue. For your procedure this may include supplemental support and reinforcement of soft tissue, such as graft placement below the urethra (suburethral) in stress urinary incontinence
(SUI) procedures, and support and reinforcement of fascial structures (a type of connective tissue) in the pelvic floor in pelvic organ prolapse procedures. The implant is provided sterile.

WARNINGS
The same medical/surgical conditions or complications that apply to any surgical procedure may occur during or following implantation. Discuss the associated risks and potential complications of this procedure with your physician. As with any human tissue implant, the potential for transmission of infectious agents may exist. A small number of patients may experience localized immunological reactions to the implant. Successful treatment is dependent upon the patient’s host tissue response. In order for this procedure to be successful, Axis Tutoplast Processed Dermis will need to be integrated and remodeled with your own tissue.

PRECAUTIONS
Axis should only be used by a qualified physician familiar with the implant and the surgical procedure. Please let your doctor know if you are not feeling well since poor general health or any conditions such as limited blood supply, compromised healing, or an active infection should be considered before use.

Tutoplast is a registered trademark of Tutogen Medical GmbH.

PM-25857 05/2023